As of 2024-12-12, the Intrinsic Value of BB Biotech AG (BION.SW) is
56.57 CHF. This BION.SW valuation is based on the model Peter Lynch Fair Value.
With the current market price of 37.00 CHF, the upside of BB Biotech AG is
52.89%.
56.57 CHF
Intrinsic Value
BION.SW Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(245.89) - (22.70) |
(37.05) |
-200.1% |
| DCF (Growth 10y) |
(22.09) - (212.71) |
(34.42) |
-193.0% |
| DCF (EBITDA 5y) |
(11.00) - (13.67) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(12.98) - (15.81) |
(1,234.50) |
-123450.0% |
| Fair Value |
56.57 - 56.57 |
56.57 |
52.89% |
| P/E |
19.32 - 33.17 |
24.66 |
-33.3% |
| EV/EBITDA |
17.79 - 37.13 |
29.14 |
-21.2% |
| EPV |
74.71 - 102.12 |
88.41 |
139.0% |
| DDM - Stable |
35.95 - 631.11 |
333.53 |
801.4% |
| DDM - Multi |
(76.70) - (953.93) |
(136.67) |
-469.4% |
BION.SW Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2,049.80 |
| Beta |
1.23 |
| Outstanding shares (mil) |
55.40 |
| Enterprise Value (mil) |
2,321.85 |
| Market risk premium |
5.10% |
| Cost of Equity |
6.36% |
| Cost of Debt |
5.00% |
| WACC |
6.19% |